FDA Approved: COTELLIC — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for COTELLIC (cobimetinib) submitted by Genentech, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Cotellic (cobimetinib)

Snippet

SUPPL AP for COTELLIC (COBIMETINIB)